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ABSTRACT
The aortic valve is a highly dynamic structure responding to actively to the chemical, mechanical
and physical cues of the valve microenvironment. Valve interstitial cells are dispersed
throughout the valve tissue and play an important role in maintaining the integrity and optimum
function of the valve. They are a heterogeneous population composed of various phenotype.
These phenotypes have specific functions characteristic of valve physiological and pathological
conditions. The effect of mechanical loading and chemical modulators on the behavior of the
valve interstitial cells have largely been studied. However the role of valve interstitial cell shape
as an intrinsic physical cue on cell behavior has not been considered yet. Based on the actively
responsive nature of the valve interstitial cells and the evidence of the relationship between
cellular shape and behavior for the other types of cells, we decided to investigate the effects of
valve interstitial cells shape on the contractile function and phenotype modulation. Various cell
shapes were designed by constraining the cells into different line/pattern widths (10µm, 20µm,
40µm, 60µm, and 80µm) using soft lithographic techniques. Cells were aligned into the lines
exhibiting varied cytoskeletal organizations. Orientation of the actin filaments significantly
decreased with increasing the pattern width. A similar trend was observed for the cell aspect ratio
and nuclear eccentricity. Contractile function of the cells was examined utilizing a custom
valavular thin film assay. All the films of the tissue construct responded to the vasoconstrictive
and vasodilatory drugs. Cellular maximum contraction did not reveal any specific trend while
cell basal tone had some statistical variations showing the maximum value for 40µm in which
cell-cell contact and cell elongation may have interacted optimally. Analysis of the contractile
and activated phenotype markers was performed using western blot on vimentin, α-smooth
muscle actin and smooth muscle myosin heavy chain. The expression of these proteins did not
change significantly for the patterns suggesting that the cell contractility may be more correlated

to the cell shape than phenotype. In conclusion we were able to modulate valve interstitial
cellular shape using soft lithographic techniques and cause alterations in cellular function. Cell
phenotype may not be a regulating factor of the cell behavior as commonly measured.
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CHAPTER ONE
INTRODUCTION
The aortic valve is a complex structure functioning in a harsh dynamic environment ensuring
unidirectional blood flow from the left ventricle into the body. It opens and closes over 2 billion
times over an average lifespan of 70 years. Previously, it was assumed to perform passively as a
result of just transvalvular pressure differences on the leaflets and contraction or relaxation of the
myocardium. However recent studies show that sophisticated mechanisms are involved in aortic
valve function affecting valvulogenesis in embryonic development [2], valve growth and
adaptation in adulthood [3, 4], and valve degeneration and dysfunction in the diseased state [5].
These mechanisms take place at the molecular, cellular and tissue levels in response to various
stimulations via signaling pathways, such as inflammation, and ECM remodeling leading to a
diseased and dysfunctional state. Heart valve diseases account for 23000 deaths annually in the
United States, with calcific aortic valve disease (CAVD) being the most prevalent [6].
(a)

(b)

http://www.cts.usc.edu/hpg-valvesoftheheart.html
Fig 1.1. Anatomical illustration of the heart showing valve chambers and leaflets, a) longitudinal
section b) axial section
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Therapeutic methods for CAVD currently include heart valve replacement through open heart
surgery or the application of a transcatheter aortic valve as a non-invasive method. Patients with
severe aortic stenosis who do not receive valve replacement have a mortality rate of 37% at 1
year after the beginning of the symptoms [7]. There is currently no medication or pharmaceutical
treatment for CAVD. Understanding the role of factors including chemical modulators,
mechanical stimulations and physical cues of the valve microenvironment that may contribute to
the initiation and progression of the diseases and their related underlying mechanisms will help
to develop new ideas to prevent the disease progression into late stages and even treatment of the
disease.
The following sections include a brief summery on the morphology, healthy and diseased stages
of the aortic valve and its tissue and cellular implications.
1-1 Aortic Valve Anatomy
The aortic valve has three leaflets named left coronary, non-coronary and right coronary, based
on their relative position to the coronary artery ostia. As it can be seen form Fig 2 each leaflet is
composed of mainly three extracellular matrix layers termed ventricularis, spongiosa, and
fibrosa. These layers have distinct chemical compositions and possess heterogeneous mechanical
behavior. The ventricularis is situated on the left ventricle side of the valve. It has high elastin
and fibrillar collagen content and is a load bearing component. The role of the ventricularis is to
facilitate elastic recoil and expansion during systole and diastole [8, 9]. The fibrosa is located on
the aortic side of the valve containing a network of circumferentially arranged collagen fibers
and it also acts as a tensile load bearing component providing the required leaflet coaptation to
maintain valve durability [10]. The spongiosa is the central layer, coupling the ventricularis and
the fibrosa and primarily composed of glycosaminoglycans (GAGs) and proteoglycans (PGs)
2

with a loose organization of dispersed collagen [8]. The hydrophilic PGs of the spongiosa act as
a cushion and lubricate local movement and shearing between fibrosa and ventricularis layers
during cyclic loading and pressurization [11].

(a)

(b)

(c)

Fig 1.2. Aortic valve structure and composition A, Normal porcine aortic valve leaflet stained
with Movat pentachrome, demonstrating the trilaminar structure, the collagen-rich fibrosa (F),
proteoglycan-rich spongiosa (S), and elastin-containing ventricularis (V). B, Aortic valve
showing early signs of valve disease, including thickening, increased matrix protein deposition
(blue) and elastin fragmentation (black). C, A calcified human aortic valve leaflet demonstrating
obvious maladaptive extracellular matrix (ECM) remodeling, including significant calcificatio[n1]
(purple)
1-2 Aortic Valve Cellular Phenotypes
There are two types of cells that reside in the aortic valve leaflet: valve endothelial cells (VECS)
and valve interstitial cells (VICs). VECs lie on both surface sides of the valve and are exposed to
distinct flow velocity and fluid shear stress conditions. The ventricular side VECs are under high
shear stress caused by high velocity systolic outflow whereas VECs that lie on the aortic side
experience the low shear stress diastolic blood flow. VECs are involved in valve homeostasis
and ECM remodeling via permeability regulation [12], inflammatory responses of adhesion
molecules [13]and paracrine signaling [14]. VECs and VICs are able to respond biologically to
the alterations caused by mechanical stimuli via a phenomenon termed mechanotransduction.
VICs lie within the body of the extracellular matrix (ECM) and exist in all three layers of the
leaflet. They communicate with each other as well as with the ECM and VECs. VICs are a
3

heterogeneous population categorized into 5 different phenotypes [15]. These phenotypes
include embryonic progenitor endothelial/mesenchymal cells, quiescent VICs (qVICs), activated
VICs (aVICs), progenitor VICs (pVICs), and osteoblastic VICs (obVICs). The embryonic
progenitor endothelial/mesenchymal cells undergo endothelial-to-mesenchymal transformation
(Endo-MT) during embryonic valve development. The qVICs are observed in normal adult
valve and regulate valve structure and integrity. The aVICs known as myofibroblasts comprise
less than 5% of the total VICs, and are increased as a pathobiological response to the disease and
injury through ECM remodeling, cell proliferation and migration. The pVICs are the least well
defined and consist of a heterogeneous population of progenitor cells that may be important in
repair. The ObVICs are osteoblast transdifferentiated VICs that regulate chondrogenesis and
osteogenesis and promote calcification.
VICs also can exhibit smooth muscle cell phenotype (SMC) in the normal and diseased valve. In
the normal valve, SMC-like VICs reside in the base of the ventricularis while in the diseased
calcified valve, they have an uncharacteristic localization to the fibrosa and spongiosa [16]. All
three activated, osteoblastic and SMC like cells are defined by specific markers characteristic of
their phenotype. Alpha-smooth muscle actin (α-SMA) expression is recognized as a marker for
aVICs. SMCs also express α-SMA as well as smooth muscle myosin heavy chain 1 and 2 that is
not expressed by the activated myofibroblasts (aVICs) [10].
The osteoblastic differentiation markers of obVICs include alkalinephosphatase (ALP) [17],
osteopontin (OPN) [18] , bone sialoprotein (BSP) [19, 20], bone morphogenetic proteins-2 and 4 (BMP-2 and -4) [21], as well as osteocalcin (OCN) [19, 22].
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1-3 Multiscale Study of Mechanobiology of Healthy and Diseased Aortic Valve
The in vitro study of normal and pathological aortic valves can be categorized into the tissue and
cellular level. Tissue based studies provide information on the differences between structural
configuration, ECM organization and the distribution of components throughout the layers while
cellular research investigates the role of mechanical stimulation and chemical modulators on the
valvular cell activation and signaling pathways through which normal cells switch their
phenotypes to the activated diseased and/or calcified cells. The advantage of in vitro cell study is
the possibility of cell isolation and examination of individual regulators assumed to influence the
valve microenvironment; co-culturing VECs and VICs yields an in vitro engineered model for
the heart valve allowing control of various factors such as substrate material and stiffness,
mechanical forces and chemical activators that mimic pathophysiological states of the valve. The
following section includes a brief review on tissue and cellular level studies of aortic valve

Fig 1.3. Multiscale hierarchy
mechanopathology. [23]
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1-4 Tissue-Level Studies
Tissue based studies of the valve provide analysis of ECM morphology under different
conditions of cyclic stretch, pressure and shear stress. ECM structural alterations (synthesis or
degradation) occur as a biological response to its mechanically changing environment that may
represent normal or pathological conditions in the valve. In an ex vivo study by Balachandran et
al, valve tissue leaflets were considered in static and stretched exposed conditions [24]. They
reported that cyclic stretch increased collagen, decreased sulfated glycosaminoglycans (sGAG),
and did not affect elastin contents of the valve ECM. They also indicated that the tri-layer
structure of the valve was not altered under stretch. Intriguingly, α-SMA content increased at the
ventricular sides of the stretched leaflets, suggesting a possible region with a focal response to
mechanical forces. In another study they investigated the role of elevated cyclic stretch on
inducing valve disease and showed cell proliferation and apoptosis was directly affected by the
cyclic stretch [25]. Their results for matrix remodeling enzymes demonstrated an increase of
collagenase, gelatinase, cathepsin S & K and matrix metalloproteinases (MMP) under higher
pathological stretch rates (20%) suggesting that increased cyclic stretch may disrupt the
homeostatic environment of the valve and contribute to the progression of the disease. They also
found that cyclic stretch increased the responsiveness of the serotonin pathway resulting in
significant enhancement of matrix remodeling and collagen proliferation.
Thayer et al indicated that the combined effect of mechanical stretch and pressure may modulate
expression of valve interstitial cell contractile phenotype markers and found that the contractile
phenotype was downregulated under hypertensive conditions suggesting that mechanical forces
induced during hypertensive condition may stimulate protective mechanisms in the aortic valve
tissue [26]
6

Finally, via alteration of the shear stress environment of the valve, Sucosky et al observed
upregulation of the expression of inflammatory markers on the aortic side of the leaflets. Their
results also suggested that noggin, a BMP-4 inhibitor, was able to mediate these inflammatory
responses [27].
1-5 Cell-Level Studies
In studies at the cellular level, cells are isolated from their ECM and cultured on two or threedimensional substrates. These constructs are stimulated in vitro with factors such as mechanical
forces and chemical stimulations to mimic the native or pathological environment of the aortic
valve disease, followed by analysis of various pathological mechanisms including inflammation,
apoptosis, proliferation and osteogenesis. Under these stimulations valvular cells also may
switch their phenotypes and express markers specific of the normal or abnormal phases of the
injured and remodeled valve.
1-6 Chemical Stimulation Studies at Cell Level
Chen et al demonstrated the role of β-catenin on the interaction between wnt and tissue growth
factor (TGF-β) signaling pathways in inducing α-SMA transcription and myofibroblast
differentiation [28]. They reported that increasing β-catenin through Wnt conditioned medium
caused TGF-β to induce higher α-SMA levels (indicative of activated VICs). They also showed
that when VICs were cultured on collagen-coated PA gels with physiological stiffness,
myofibroblast activation was limited to matrices with fibrosa-like stiffness possibly explaining
why the fibrosa is more prone to the disease.
Osman et al showed that VICs are capable of differentiating into osteoblast like phenotypes via
applying defined mediators such as bone morphogenic proteins (BMP-4, BMP-2) and TGF-β.
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Atorvastatin could decrease alkaline phosphatase (ALP) activity and osteoblast differentiation
highlighting its potential as a possible therapeutic agent against CAVD [29].
In a study by Metzler et al, it was shown that imposing stretch on the VECs caused an
upregulation in the expression of proinflammatory markers Intercellular Adhesion Molecule
(1ICAM-1) and Vascular Adhesion Molecule 1 (VCAM-1) that are known to be present in the
endothelium of the diseased aortic valve [30].
The contribution of TGF-β to aortic valve calcification was studied by Clark et al through
alizarin red staining, ALP activity and analysis of cell apoptosis. The results showed that VICs
treated with TGF-β had significantly more regions stained positive for alizarin red as an indicator
of the stenotic diseased VICs. An increased level of ALP activity and higher apoptotic rate
induced by TGF-β confirmed the mechanistic role of this osteogentic marker in initiation and
progression of the calcific AV [31].
Yip et al cultured VICs on gels with different stiffness and found that calcification was regulated
by ECM stiffness. They observed that either osteogenic or myofibrogenic differentiation of VICs
can result in calcification in vitro through two distinct processes respectively mimicking aspects
of either bone formation or apoptosis-associated calcification in vivo [32].
Signaling pathways such as MPEK/ERK/Rho have also a regulatory effect in aortic valve
calcification and their inhibition may reverse the activated or osteogenic VICs to a normal
quiescent phenotype [33, 34].
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1-7 Mechanical Stimulation Studies at Cell Level
Kloxin et al studied the influence of microenvironment activity on myofibroblast activation by
culturing VICs on a high modulus activating hydrogel. The authors reported that decreasing the
substrate modulus with irradiation reverses this activation, demonstrating that myofibroblasts can
be de-activated solely by changing the modulus of the underlying substrate [35].
Balachandran et al indicated that EMT (Endothelial Mesenchymal Transformation) of the VECs
was elevated under cyclic stretch via increased α-SMA expression and reduced cadherin-positive
cells. They also showed that EMT induced tissue generated higher contraction in response to
vasoconstrictive drugs indicating the possible regulatory effect of EMT on valve function [36].
The above review contained a brief summary on the role of mechanical and chemical stimulation
on mediating valve microenvironment mimicking patho-physiological conditions. However the
effect of the cell shape as a physical cue that may intrinsically regulate valve function has not
been studied yet. There are several studies for other types of cells that have considered the role of
the cell shape on important cellular functions such as cell death and growth, machrophage
lineage and stem cell differentiation that will be discussed in the next section.
1-8 Cell Shape on Other Cell Types
The relationship between cell shape, size and organization with cell function have been
extensively studied for different cell types. The effect of capillary endothelial cell shape on cell
death and growth was studied by Chen et al and the results showed that cells cultured on single
large circles (20 µm) had a significantly greater apoptosis index than multiple smaller circles
while indicating higher growth index values [37]. They also found that integrin ligands regulated
the apoptosis rate for unpatterned and patterned cells. Nelson et al microfabricated pulmonary
endothelial multicellular sheets of square and annulus shape with varying sizes and reported that
9

the rate and pattern of the proliferation is dependent on the geometry of the monolayer [38].
They also proposed that patterns of mechanical stress may be derived by the organization of the
cells and may define various proliferation patterns (depicted in Fig. 1.5). In a comprehensive
study by Versaevel et al the mechanistic regulation between cell and nuclear shape was
investigated emphasizing the role of actin fibers and cell shape area in nuclear remodeling
process [39]. They reported that nuclear shape is regulated with the lateral forces generated by
the tension in actomyosin fibers that expands as the cells become more elongated. Their results
also showed that when intermediate filaments are disrupted for elongated cells, the volume
architecture decreased to keep the balance of the intracellular forces. This volume loss that
affected chromatin condensation and cell proliferation causing nuclear stiffening. Cells that had a
circular shape, however, were not affected by treating with interfilament inhibition, confirming
that the nucleus of circular-shaped cells was not altered by tension in actomyosin filaments.
(a)

(b)

(c)

Fig 1.5. Mechanical forces generated by cytoskeletal contraction cause the patterns of
proliferation. (a) Vector map of traction forces measured at edges (b) Colorimetric map of
traction forces measured over the entire monolayer (nN) (c) Colorimetric images of cell
proliferation for cells cultured on asymmetric annulus. [38]
Mcworker et al studied the effect of the physical environment on modulation of the
proinflammatory (M1) and prohealing (M2) activation states of macrophages [40]. They cultured
machrophages on unpatterened (control) and micropatterened surfaces containing different wide
lines and found that cell elongation caused the higher expression levels of M2 polarization
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markers including arginase-1, CD206 (known as mannose receptor C, type 1), and YM-1 (a
machrophage pretein) but did not induce any change in expression of M1- polarization state.
They also observed that proinflammatory markers including interleukin (IL). CD54, IFN-γ
(interferon), and macrophage inflammatory protein-1α were decreased by cell elongation. They
concluded that cell shape itself polarizes macrophages toward an M2 phenotype and that
combined with cytokines its effect on polarization state would be enhanced.
Mcbeath et al found that commitment of the human mesenchymal stem cells (hMSCs) was
mediated by cell shape via RhoA signaling [41]. The cells that were allowed to adhere and
spread on the surface differentiated to osteoblasts whereas unspread round cells differentiated
into adiopocyets. Active RhoA caused osteogenesis while dominant-negative RhoA induced
adiopocyte lineage.
(a)

(d)

(b)

(c)

(e)

(f)

Fig 1.6. The absence of a preferential axis of organization is observed for circular myocytes. (a,d)
immunofluorescent stains for F-actin (b,e) immunofluorescent stains sarcomeric a-actinin, (c,f) the
averaged distribution of F-actin
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Kilian et al also investigated the relation between the shape of the hMSCs and cell differentiation
[42]. They cultured cells in rectangles with different aspect ratios and pentagonal shapes with
various curvatures, and observed that the patterns that promote contractility shifted toward
osteoblast while less contraction-inducing patterns differentiated into adiopocytes. Their results
also revealed that cytoskeletal disrupting agents modulated the shape dependent commitment of
the cells emphasizing the essential role of myosin contractility created in differentiation.
Parker et al studied directed cell motility in a cell shape controlled manner [43]. When cells were
cultured on the square islands with motility factors, they extended their lamellipodia from the
corners with the stress fibers oriented such that the tractional forces focused on the corner
regions, indicating the ability of square cells to localize focal adhesions. Bray et al considered
the effect of cell shape on sarcomere alignment [44]. Myocytes cultured on circular ECM did not
align their sarcomeres and actin in predictable patterns while rectangular myocytes assemble
predictable and repeatable actin network and aligned sarcomeres. Also, they reported that
increasing aspect ratio for rectangular patterns, spatial anisotropy, including aligned myofibrils
and the registration of adjacent sarcomeres registration, emerges, introducing myocyte shape as
an important potential regulator of myocyte contractility. Alford et al cultured vascular small
muscle cells (VSMCs) on different rectangular patterns and revealed that cell contractile stress
decreased by increasing the pattern width [45]. However the opposite trend was observed for
contractile phenotype expression suggesting that phenotype measurement may not be reliably
applicable for VSMC contractile behavior.
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1-9 Motivation for Thesis
The effect of VIC shape on cellular function and phenotype has not been studied yet. In this
thesis, we considered the possible regulatory role of the VIC shape on valve contractile output
and phenotype by performing various assays to quantify cell structure, phenotype and
contractility.
1-10 Hypothesis and Objectives
We hypothesized that VIC shape can modulate the phenotype and function of the cell.
For proof-of-concept of the hypothesis of this thesis, we stained nuclei of the paraffin embedded
sections of normal and calcified human heart valve tissues (obtained from University of
Arkansas for Medical Sciences tissue bank) and measured nuclear aspect ratio of the cells. As
observed in Fig 3.1, there was a significant difference between healthy and diseased group
suggesting the possibility of structural alterations in cell geometry of the valve. Specifically, we
noted a decrease in the eccentricity in disease tissue suggesting that there is a reduction in
parameters of cellular architecture correlating with disease.
*

(b)

(a)
Calcified

Nuclear Eccentricity

Healthy

1.0

0.8
0.6

H

C

Fig 3.1 (a) Dapi staining of the nuclei for healthy and calcified human aortic valve tissue (b)
nuclear eccentricity measurements for healthy and calcified valves (n=3, p<0.005)
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The hypothesis was examined via four main objectives as listed as below:
1) Design a method to change the shape of the VIC in vitro.
2) Quantify change in the cell shape.
3) Analyze change in cell function due to change in shape.
4) Analyze change in cell phenotype due to change in shape.
The experiments performed regarding the objectives are categorized as follows:
1) Mask design, wafer preparation and microcontact printing
2) Immunofluorescent staining of cellular architecture and quantifying metrics for
cell shape
3) Valve thin film assay
4) Western blotting and protein expression
Each of these assays will be explained in detail in the following chapter.
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CHAPTER TWO
MATERIALS AND METHODS
2-1 Cell Isolation
Fresh porcine aortic valves were obtained from local slaughterhouses (Braunschweig, Neosho,
MO and Cockrum, Rudy, AR) and transferred to sterile Phosphate Buffered Saline (PBS, Gibco)
on a bucket of ice. Aseptic procedures were adopted upon arrival to the laboratory. The leaflets
were dissected and placed in collagenase (Worthington, Lakewood, NJ) and dispase
supplemented Hank's Balanced Salt Solution (HBSS) (Gibco, Grand Island, NY) with respective
concentrations of 60U/ml and 2U/ml. The solution then was incubated for 2 hours with gentle
agitation every 15 mins to extract the valve endothelial cells (VECs). Leaflets were then
transferred to fresh enzyme solution, The VEC digestate was not utilized for the experiments in
the current project. Fresh enzyme solution was then incubated for two hours as before. Digested
VICs were then centrifuged and the cell pellet was suspended in complete media comprising
Dulbecco’s Modified Eagle Medium (DMEM), 10% fetal bovine serum (FBS), and 1%
penicillin/streptomycin and 1% HEPES (all from Gibco) and cultured using standard cell culture
methods. All experiments outlined below were performed using cells from passages 3–7.
2-2 Mask Design and Soft Lithography
A photomask was designed using AutoCAD comprising five squares (1.7cm2). The squares
accommodated lines with 10, 20, 40, 60, and 80 μm widths, respectively, spaced by 40 μm gaps.
(Fig 2.1) A transparency photomask was manufactured by (Outputcity Inc.) and used to prepare
the silicon substrate master via standard photolithography techniques. Briefly, a 10 μm thick
layer of SU-8 3005 (Microchem, Westborough, MA) was spin-coated onto a silicon wafer. The
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mask was then placed in alignment with the wafer inside the mask aligner (SUS Microtech) and
clamps and vacuum were applied to ensure tight contact.
(a)

(b)

Fig 2.1(a) Mask includes 5 different line widths, designed by AutoCad (b) Silicon wafer with
high raised features
Ultraviolet light (wavelength and power) exposure was used to transfer the mask pattern to the
wafer. The portion of the uncured SU-8 not exposed to UV light was washed away using SU-8
developer and iso-propyl alcohol. The wafer was then silanized overnight using (Trichlosaline,
UCT SPECIALITIES, LLC, Bristol, PA) and the wafer with 10 µm raised rectangular features
was ready to use for stamp preparation and soft lithography. (Fig 2.1)
The silicon wafer with rectangular features was first cleaned using acetone, methanol and
isopropyl alcohol and dried. 100g of PDMS, polydimethylsiloxane (Sylgard 184 Dow Corning,
Midland, MI) was poured over the wafer placed in a petri dish and cured inside oven for at least
4 hours at 65°C. The PDMS template was then removed from the silicon wafer and the
individual stamp patterns (i.e. different line widths) were cut out and stored. (Fig 2.2)
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(a)

(b)

(c)

(e)

(d)

Fig 2.2 Stamp preparation (a) making PDMS solution (b) mixing PDMS and curing agent
(c) degassing PDMS through vacuum (d) pouring PDMS on top of the wafer (e) PDMS
stamps peeled off of the wafer and cut out
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2-3 Micro-contact Printing
2-3-1 Cell Substrate Preparation for Protein Blotting
VICs were seeded on a specially prepared substrate that had the microcontact printed line widths
as follows. Substrate was prepared by spin-coating a thin layer of PDMS on a clean 25mm glass
coverslip (VWR) and curing overnight at 65°C. PDMS stamps were incubated with 1%
Fibronectin solution (Corning) for one hour and then air-dried. PDMS coated substrate was UVozone treated for 20 min and the stamps were placed on the substrate surface and pressed slightly
to transfer fibronectin features. The stamps then were gently peeled off of the substrate; coverslip
substrates then were incubated with 10% pluronic solution for 8-12 min to prevent cell adhesion
to the non-fibronectin coated area (gaps between the different line widths) and the VICs were
seeded at 500,000-700,000 cells per coverslip.
cells

fibronectin coated
stamp

Fig 2.3 Schematic of micro-contact printing technique

The process of wafer fabrication, stamp preparation and micro-contact printing has been
summarized in a schematic of Fig 2.4.
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Fig 2.4 Schematic of the stamp fabrication and micro-contact printing process for ECM proteins
to PDMS coated coverslips [46]

2-3-2 Cell Substrate Preparation for Valve Thin Film Assay
Substrates were prepared differently for the valve thin film assay as we wished to obtain a freely
floating PDMS film that is not attached to the underlying glass coverslip. As the schematic in Fig
2.5 shows, coverglass surface was covered using plastic tape (Patco) and a rectangle was cut off
at the center of the coverglass. This rectangular area was spincoated with a thin layer of PIPAAm
(Poly-N-Isopropylacrylamide, Sigma-Aldrich, St. Louis, MO/ Polyscience Inc, Warrington, PA);
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the remaining tape was peeled away and the coverslip was spin-coated with PDMS as previously
described. In this method, no pluronic was needed after printing.

plastic tape

PIPAAM
coated area

PDMS

2 layer cell substrate

Fig 2.5 Schematic of the substrate preparation for the valvular thin film experiment.
2-4 Valve Thin Film Assay
The valve thin film (vTF) assay follows the protocol utilized for vascular smooth muscle cells
[36, 45]. This assay was performed 48 hours after the cell culture in which tissue constructs
cultured on coverglass were transferred to a petri-dish containing Tyrode’s buffer; the rectangle
PIPAAm coated area was cut into strips (films) parallel to the alignment of seeded VICs. The
solution was allowed to cool below 32°C to dissolve the PIPAAm layer and release the cell and
PDMS layers. Solution temperature was set at 37°C for the duration of the experiment. After 2.5
min of temperature stabiliziation, vTFs were stimulated with 50 nM endothelin-1, a
vasoconstrictor, (ET-1, Sigma Aldrich) to curl the films for 15 minutes followed by treatment
with 100 μM fasudil, a vasodilator, (HA-1077, Sigma Aldrich) for 30 minutes. The images were
taken under a stereoscope (Lecia Microsytems, Buffalo Groves, IL) at 15s intervals and then
analyzed using ImageJ (Opensource, NIH) and MATLAB (Mathworks, Natick, MA) to
determine radius of curvature and cellular stress required to bend the films (Fig 2.6).
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(a)

(b)

Fig 2.6 (a) Thin films were cut on the PIPAAM layer (b) projection length of the film at the
initial state, after ET-1 and HA-1077 treatments.
The length of the film (L) was measured when the film was flattened on the coverslip surface.
Eq 2.1(a) was used to numerically measure th e projection le ngth of the film on the coverslip
plane (x) and (r) at each time point. Eq 2.1(b) measures the stress (σ) having the following
parameters:
(E): PDMS elastic modulus, (t): PDMS thickness, (h): Tissue thickness, (υ): Poisson's ratio of
PDMS and (r): Radius of curvature derived from Eq 2.1(a).
(a)

(b)

Eq 2.1

2-5 Fluorescent staining for cell and nuclear architecture analysis
Cells were fixed and stained for nuclei (DAPI, Life Technologies) and F-actin (phalloidin, Life
Technologies) and imaged using a regular upright inverted microscope at 40X magnification for
analysis of actin alignment. Actin alignments were quantified by analyzing the phalloidin stained
images in MATLAB. The program, updated by Dr. Balachandran, was a customized version of a
fingerprint detection algorithm (Peter Kovesi, University of Western Australia) in which actin
filaments were detected as ridge-like regions and the ridge-mask coupled with vectors oriented
along the ridges was used to give the orientation parameter as a quantitative measurements for
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the alignment. Orientation parameter ranges from 0 for un-aligned isotropic filaments to 1 for
perfectly aligned filaments.
Nuclear eccentricity was analyzed using a custom-developed MATLAB code [36]. Eccentricity
is a normalized measure for the aspect ratio of the nucleus, where 1 represents a 1-dimensional
line and 0 represents a perfect circle. The equation for eccentricity is shown as Eq. 2.2.

Eq 2.2

Cells from separate experiments were live-stained with GFP-plasma membrane stain (Life
Technologies) and similarly imaged. Cell aspect ratio was quantified via images of the live
stained plasma membrane in ImageJ by manually fitting an ellipse to the cell membrane and
measuring major and minor axes values.
Actin, nuclear and cell aspect ratio parameters were quantified for at least ten images per sample
from a total of 4-6 samples.
2-6 Western Blotting
Western blotting allows quantitative measurement of the proteins of interest using specific
antibodies. Prior to western blot, cell lysate containing the proteins were collected using RIPA
buffer (Santa-Cruz, Santa Cruz, CA) and centrifuged at 21,000 rpm to pellet the cell debris. The
supernatant was analyzed via BCA protein assay to quantify the protein concentration. Following
protein assay, equal amounts of the proteins (35 µg) were separated based on their molecular
weights using Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE) in a 415% gel at 200V constant voltage. Proteins were then transferred to a Polyvinyl Fluoride
(PVDF) membrane at 150V constant voltage at 4°C. The membranes were incubated in blocking
23

buffer (LI-COR Biosceince, Linclon, NB), primary and IR-Dye conjugated secondary antibody
solutions and scanned using a LiCor Odyssey scanner (LI-COR). The obtained images of the
membranes then were analyzed through ImageJ to quantify protein expression by measuring the
intensity of the expressed protein bands. The antibodies used, and their respective concentrations
are tabulated in Table 2.1.
Antibody

Concentration

α-SMA

1:100

Vimentin

1:100

Smooth Muscle Heavy Chain
(SMMHC)
β-actin

1:25
1:1000

Table 2.1 Antibodies used for western blot and their relative concentrations
2-7 Statistical Analysis
All data was presented as mean ± standard error. Minitab software (Minitab release 14, Minitab
Inc. State College, PA), Excel (Microsoft Corp, Bellevue, WA) and Prism (GraphPad Software
Inc, La Jolla, CA) were used for the analyses. The difference between the samples were assumed
significant if the p-value < 0.05. Student t-tests were used for testing the difference between
sample groups when the data follow a normal distribution, and only two groups are being
compared. ANOVA was applied for the analysis with Tukey’s post-hoc test for the comparison
between more than two groups. For data not normally distributed, Kruskal-Wallis and Dunn’s
method on pairwise comparisons were used replacing student t-tests and ANOVA respectively.
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CHAPTER THREE
RESULTS
3-1 In vitro model for altered cell shape
As we mentioned earlier, to prepare an in vitro model of the various cell shapes, we designed a
mask from which a silicon wafer was fabricated and utilized as a template for making PDMS
stamps. The stamps were used in micro-contact printing and formed the desired high raised lines
on the cell substrate. Fig 3.1 shows the pictures of the cells aligned into five different line widths.
10µm

20µm

40µm

60µm

80µm

Fig 3.1 Bright field images of VICs micro-patterned into thin tissue lines of different widths,
separated by 40 mm gaps.
3-2 Role of cell shape on valve interstitial cell architecture
We designed structural patterns for the VICs including rectangles of 5 different widths and asked
if these patterns could indicate similar variations in cellular geometry and organization.
Structural analysis was performed for the actin alignment and cell shape by staining actin
filaments and nuclei and measuring orientation parameter (OP) and cell aspect ratio. As depicted
in Fig. 3.2, a trend for decreasing OP and cell aspect ratio was seen by increasing the pattern
width. Results showed that actin architecture was more than 80% aligned (OP>0.8) for all the
patterns. However there was a significant difference between narrow patterns (10 and 20) and
wide patterns (40, 60, and 80).
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(a)

(b)
1.00

OP

0.95
0.90

*

** *
*

0.85
0.80
10μm

20μm

40μm

60μm

80μm

10μm 20μm 40μm 60μm 80μm

Fig 3.2 Histochemical analysis of different tissue constructs. (a) Actin filaments stained for
phaloidin and nuclei stained for DAPI (b) Alignment of the actin filaments was measured by
Orientation Parameter (OP)

Cell aspect ratio was obtained by live staining of the cell membrane. Using ImageJ, each cell was
estimated with an ellipse and the aspect ratio was determined by dividing minor axis to the major
axis of the ellipse. Results showed dominant variations changing from high values of 10 for
10μm width to 4 for 80μm width. Statistical analysis revealed significant difference between
almost all of the groups. (Fig 3.3) Nuclear eccentricity data obtained from DAPI staining of the
tissue patterns and similar to the aspect ratio values, had significant difference between almost
all of the groups. Nuclear eccentricity was higher for thinner patterns and were reduced by
increasing the pattern width (Fig 3.3).
We also noted that there was a correlation between cell aspect ratio and nuclear eccentricity that
was in agreement with other studies. [45, 47]
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(a)

10

*

**

*
*
*

5
10μm 20μm 40μm 60μm 80μm

(d)

*

1.0

*

*

0.9
0.8
0.7
10μm 20μm 40μm 60μm 80μm

Cell Aspect Ratio

15

(c)
Nuclear Eccentricity

Cell Aspect Ratio

(b)

14
10
6
2
0.7

0.8

0.9

1

Nuclear Eccentricity

Fig 3.3 (a) Membrane of the cells live stained and imaged with green plasma membrane stain (b)
cell aspect ratio(c) nuclear eccentricity(d) Correlation between cell aspect ratio and nuclear
eccentricity (r=0.9, p=0.08) (*: statistical difference<0.05)

3-3 Role of cell shape on valve interstitial cell function
As the next step, functional behavior of the VICs were studied via the valvular thin film assay
(vTF) and stress values were calculated for all the patterns. As illustrated in Fig 3.3, all the tissue
patterns responded to the stimulation. ET-1 induced contraction and increased the stress and HA1077 caused the films to relax and reduced the stress. Maximum contraction and basal tone were
calculated and demonstrated in Fig 3.4. One way ANOVA of contraction stress compared stress
values for various pattern widths and confirmed that they were not significantly different.
However comparison of basal tone between them revealed statistical differences between 10μm
and 40μm and also 40μm and 60μm. (Fig 3.9)
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Fig 3.4 Temporal apparent stress for serial stimulations of 10μm VTFs with endothelin 1
followed by HA-1077

Fig 3.5 Temporal apparent stress for serial stimulations of 20μm VTFs with endothelin 1
followed by HA-1077
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Fig 3.6 Temporal apparent stress for serial stimulations VTFs with 40μm of endothelin 1
followed by HA-1077

Fig 3.7 Temporal apparent stress for serial stimulations of 60μm VTFs with endothelin 1
followed by HA-1077
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Fig 3.8 Temporal apparent stress for serial stimulation of 80μm VTF with endothelin-1 followed
by HA-1077
(a)
(b)
2.5

Basal Tone (MPa)

Contraction (MPa)

1.0
0.8
0.6

0.4
0.2
0

2.0

*

*
P<0.05

1.5

1.0
0.5
0
10µm 20µm 40µm 60µm 80µm

10µm 20µm 40µm 60µm 80µm

Fig 3.9 (a) Tissue contraction induced by 50 nM ET-1 stimulation for all tissues. (b) Basal
contractile tone for all tissues.
3-4 Role of cell shape on valve interstitial cell phenotype
Phenotypic study of the VICs was investigated by western blotting. Western blot allows to
analyze the expression of the proteins specific of contractile and activated phenotype. Three
proteins were analyzed including α-Smooth Muscle Actin (α-SMA), Vimentin (Vim) and
Smooth muscle heavy chain (SM-MHC). These proteins are recognized as the markers of
contractile and activated phenotypes. We used to these proteins to determine if the changes in
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contractile behavior of the VICs was induced by their phenotypic switching. Table 3.1 shows
these antibodies and their relation to myofibroblasts and smooth muscle cells. SMMHC and Vim
are recognized as contractile markers and α-SMA as the marker for activated phenotype.
α-SMA and Vim did not follow a decreasing or increasing trend. A trend for increasing SMMHC
expression was observed by increasing the pattern width. No statistically significant difference
were apparent between different groups for all the phenotypes. These results suggest the
phenotype was mixed within our samples and therefore may not be a reliable indicator of the
contractile function of the cells.

Antibody

Vimentin

Filament System

Intermediate /

Activated

Smooth Muscle

Myofibroblasts

Cells

+

+/-

mesenchymal
α-SMA

Microfilament actin

+/-

+

SM1 + 2

Myosin heavy chain

-

+

Table 3.1 Antibodies used to describe activated and smooth muscle cell phenotype
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(b) 1.5

(a)

Fold Change

α-SMA
Vimentin
SMMHC
β-actin

1.0
0.5
0.0

10μm 20μm 40μm 60μm 80μm

1.0
0.5
0.0

4.0

Vimentin Expression
Fold Change

1.5
Fold Change

10μm 20μm 40μm 60μm 80μm

(d)

(c)

[45]

α-SMA Expression

SMMHC Expression

3.0
2.0
1.0
0.0
10μm 20μm 40μm 60μm 80μm

10μm 20μm 40μm 60μm 80μm

Fig 3.10 Western blot for contractile markers, α-SMA, Vimentin, and smooth muscle myosin
heavy chain (SMMHC). Normalized quantified expression with β-actin for (b) α-SMA, (c)
Vimentin, and (d) SMMH
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CHAPTER FOUR
DISCUSSION

A discussion our results and limitations are presented below. Using micro-contact printed tissue
patterns with constrained boundary conditions, we studied the cell shape alteration, cell
phenotype, cell functional stress and the possible relationship between them.
Cell aspect ratio varied significantly depending on the pattern width used, however their
differences seemed not to have a large effect on contractile behavior and cell phenotype. Cell
aspect ratio varied from approximately 10 for thinnest pattern to 5 for the widest. All these
patterns depicted a spindle shape in this range. If the VICs were able to adopt a rhomboid or
circular shape, more variation may have been observable in the expression of protein markers
and functional behavior. This was probably an indication of the stable nature of the VIC shape,
function and phenotype. Future studies should therefore consider longer culture durations than
48 hours to examine if there are significant changes in VIC function and phenotype due to
altered cell shape.
Orientation parameter indicated high alignment for all the patterns with a trend for decreasing in
wider patterns that is due to the higher cell density. When cells were restricted into thin lines (10
and 20) less number of cells were present and actin filaments have less space to spread out
forcing them to align in almost the same direction having higher alignment. The significant
difference between the alignments of the different tissue lines may explain the role of the
cytoskeletal organization on functional differences of the cells.
Phenotypic switching of the heart valve cells is traditionally considered to be indicative of
normal or diseased conditions. Quiescent VICs (qVICs) have been characterized as having
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synthetic phenotypes. These VICs are observed in a normal adult aortic valve and exhibit little or
no cell proliferation and control valve homeostasis through mediating ECM collagen thickness
and alignment [4]. Under injury or disease, qVICs become activated and possess characteristics
of myofibroblasts exhibiting elevated contraction, stress fibers and contractile proteins such as αSMA, vimentin and myosin heavy chain that are not present in qVICs [48, 49]. Myofibroblasts
have been shown to affect ECM remodeling [49, 50], cell proliferation and migration [51] and
are also related to apoptosis [52]. Vimentin is a type III intermediate filament covering the heart
chambers and inner surfaces of large blood vessels. Based on Schnittler et al, the content of
vimentin was predominantly higher in more dynamic environments such as the aorta, pulmonary
trunk and left ventricle as compared to lower stress hemodynamic environments such as vena
cava, atria and right ventricle, suggesting the adaptive response of the cytoskeleton to the
changing mechanical loading by the possible role of the vimentin in helping endothelial cells to
endure high blood pressure and flow. [53]
In this research work we investigated the expression of these three markers and their possible
role in altering valvular function. Our results showed that smooth muscle myosin heavy chain
(SMMHC) and α-SMA were expressed for all the patterns showing their capability in stimulating
the diseased phenotype. Vimentin was also strongly expressed for all the tissue constructs
confirming the possible existence of the qVICs. However we could not clearly distinguish
qVICs, as both aVICs and qVICs express Vimentin [49]. SMMHC is recognized as the basic
marker of contractile SMC and was expressed at a lesser extent than Vimentin and α-SMA for all
the tissue patterns confirmed by previous studies verifying SMC expression in the aortic valve
[54] and the basement of the ventricularis [55, 56]. Again, since α-SMA is shared by both aVIC
and SMCs, activated myofibroblasts cannot be differentiated from SMCs. It is therefore
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suggested that VICs are isolated separately from different layers of the valve (fibrosa, spongiosa,
ventricularies) during cell harvest to allow for differentiating various cell phenotypes (quiescent,
activated myofibroblasts and smooth muscle like cells) and to provide a comparison between
functional behavior of the layers at the cellular level. This may also render a more accurate
phenotype of the cells observable in ex vivo conditions. Comparing the expression of the proteins
between all the patterns did not reveal a significant difference, suggesting that VICs exist as a
continuum of phenotypes in vitro. However a trend for increasing SMMHC may suggest that
wider patterns may promote pathological conditions leading to aortic valve disease initiation and
progression [16].
The results from this thesis also are in agreement with other studies that higher cell-cell contact,
in wider patterns here, cause an increase in contractile phenotype [45, 57, 58]. Stress data for the
patterns followed an almost similar trend to the phenotype curves however there are some
deviations for 60μm lines in the contraction regime and wider lines (60μm and 80μm) in basal
tone suggesting that contractility of the tissue may not be induced by phenotype alterations as
assumed previously and that there may be some other factors besides the actin and nuclear
cytoskeleton in determining the mechanical features and consequently functional behavior of the
cells.
Moreover it was noted that both cell elongation and cell-cell contact act to increase the cell
contractility. Cells were more elongated and have higher aspect ratio in thinner patterns and
more cell-cell contact exist in wider patterns. The results for the contractile basal tone may
therefore suggest that both of these effects may have produced the maximum value for 40μm
lines as the middle range line width. However further investigation is required to separately
consider and quantify cell-cell contact and its relevance to the heterogeneity of the stress
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response in contraction and basal tone. Moreover cell coverage percentage is another factor that
may affect the accuracy of the results. Lower stress data may arise from the fact that lower
surface area of the cells have been covered by the cells. If this area would be measurable during
the thin film experiment, stress values could have been normalized by that metric, thereby
providing more reliable results to compare the differences between various pattern widths.
Focal adhesions (FA) are macromolecular assemblies that transmit mechanical forces and
regulate signals between the ECM and the interacting cell. FA size has been recognized to
transduce cell shape signals into contractility by controlling cellular traction and reported to have
a significant effect on cell survival [37, 59-61]. Another study showed that the mechanical output
of the cell was regulated by spread area alone. They reported that despite having an increased
number of focal adhesions as a result of increasing spread area, FA number was associated with
an increase in strain-energy for unconfined geometries and concluded that FA may not regulate
the mechanical work done by the whole cell [61]. Based on the above mentioned studies it is
recommended to consider the effects that focal adhesion size and number may have on cell shape
and functional stress for further studies of this work.
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CHAPTER FIVE
Conclusions and Future Directions

This study indicated the effect of the geometry of the valve interstitial cells on the functional cell
behavior and phenotype. The findings of this work can be outlined as follows:
•

We could successfully construct tissue in vitro with various structural organizations.
Orientation parameter, cell aspect ratio and nuclear eccentricity data varied among
different tissue pattern widths.

•

Valve thin film functional assay indicated that cells were responsive to chemical
stimulations induced by vasoconstriction and vasodilation drugs.

•

The contractility behavior of the VICs was likely influenced by the cell elongation and
cell-cell contact; the former more dominant in thinner patterns and the latter in wider
patterns that may be correlated to the variations of the contraction and basal tone for the
patterns.

•

Basal tone had the maximum value for 40μm patterns in which the effects of cell-cell
contact and cell elongation may have optimally superposed.

•

Phenotype did not significantly vary between the patterns suggesting that functional
changes were due to the alteration of shape alone.

The following suggestions may be considered as future directions of this work:
•

Assessing the cell coverage area for the thin film assay:
Some empty spaces may be observable on the cell substrate after the cell culture due to
improper micro-contact printing and artifacts of the wafer that has transferred to the
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stamps. This may affect the amount of the stress generated by the cells and can be
included in stress assessment by normalizing the stress with the cell coverage percent.
•

Determining cell and PDMS thickness for each thin film experiment:
In this study we assumed the thickness of the myocardium for the VICs. It is
recommended to calculate the thickness of the tissue for each individual patterns using
live or fixed and fluorescently stained cells combined with confocal z-stack imaging.
Moreover the thickness of the PDMS (t) is changing with the curing time prior to spincoating [62] for the cell substrate preparation (described in section 2-3) and the stress
value (σ) in Eq 2.1 is proportional to t3 confirming the significance of having an accurate
thickness for the stress measurements. Thus it is recommend to directly measure the
PDMS thickness using a profilometer.

•

Running western blot for the other proteins markers:
In this study we studied three markers of contractile and smooth muscle cell phenotype.
Considering the markers for calcification and inflammation such as OPN, OCN, ICAM,
VCAM, and signaling pathways such as ERK and TGF-β may explain if the patterns can
mimic calcified conditions of the valve.

•

Performing the experiments in longer periods after the culture (5-7-14 days):
This will allow us to consider how time may influence the changes in cell function and
phenotype.

•

Investigating the focal adhesion and its role on regulating the cell shape.
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APPENDIX
MATLAB CODE
%% This code is written for the stress calculation of the thin film assay.
%% The microscope images should be converted to binary images first and then
inserted here.
%% It will first remove the noises and gives a picture that just contains the
projected line of the thin film.
%% It then calculates the distance of the line from the baseline to give the
radius of the curvature.
%% Stress values are the obtained based on the radius of the curvature and
physical properties of the PDMS layer.
%%
%length analysis
clear;
close all;
clc;
%number of frames
q=input('input the number of frames ');
[file,path]=uigetfile({'*.TIF';'*.tif';'*.bmp';'*.jpg';'*.*'});
filename = [path file];
f=71;g=126;
for i=1:q
%for i=1:f
%for i=72:g
im= imread(filename,i);
%% noise removal by discarting elements with low number of pixels
CC = bwconncomp(im);
for j=1:CC.NumObjects
if numel(CC.PixelIdxList{j})<200;
im(CC.PixelIdxList{j})=0;
end
end
% finding the index of rows
% dist(j) will contain distance from bottom in column j
S=0;I=0;
for j=1:size(im,2)
t_row = max(find(im(:,j)));
if ~isempty(t_row)
%dist(j)=size(im,1)-t_row;
dist(j)=t_row;
S=S+dist(j);I=I+1;
else
dist(j)=-1;
end
end
%the length are in micrometers
%10000 um/#pixels measured in imagej (when scale is 1 cm)
% "ps" represents pixel size and may vary for each experiment based on the
microscope set up
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%(It is recommended to calculate pixel size for each experiment
%ps=1.014;
ps=1.025;
im1=imshow(im);
avg_pdist(i)=S/I;
avg_dist(i)=ps.*avg_pdist(i);
end
% disp(avg_dist)
L=size(im,1)*ps;%x=L-avg_dist;
x=avg_dist;
% stress calculations
E=1.5; %MPa pdms elastic modulus
t=30; %um pdms thickness
h=5; %um 2D myocardium thickness
nu=.49; %poisson's ratio of pdms
%R is the radius of curvature for each frame of the video
%%
x=transpose(x);r=zeros(q,1);stress=zeros(q,1);
%x=transpose(x);r=zeros(f,1);stress=zeros(f,1);
%x=transpose(x);r=zeros(g,1);stress=zeros(g,1);

for i=1:q
%for i=1:f
%for i=72:g
if x(i)<L && x(i)>2*L/pi
r(i)=fzero(@(R)radius(x(i),R,L),50);
else if x(i)<2*L/pi
r(i)=x(i);
end
end
stress(i)=(E*(t^3))./(6.*r(i)*(1-nu)*(h^2)*(1+t/h));
% stress(i)=70.13/r(i);
end
%%
% stress=transpose(stress);
% time=0:15:((15*q)-15);
% figure(1)
% plot(time,stress,'.')
% xlabel('time (s)')
% ylabel('stress (MPa)')
%%
%stress
%% Stress values are neglected before adding the ET-1 at 2.5min=12*15sec
finalstress=stress(12:q)-stress(12);
normalstress=1e+3*finalstress/L;
time=transpose([12*15:15:q*15]);
figure(2)
%% The stress values are normalized with the length of the picture(MPA/mm)
normalstress=1e+3*finalstress/L
% figure(2)
%plot(time,stress)
plot(time,finalstress)
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